Related Experiment Video
Updated: Jun 13, 2025

Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
Extragastrointestinal stromal tumors with diffuse membranous distribution with bleeding: A case report.
Jian-Duo Xu1, Zheng Wang2, Qian Zhou3
1Department of Gastrointestinal Surgery, Shijiazhuang People's Hospital, Shijiazhuang 050000, Hebei Province, China.
This case report details a rare extragastrointestinal stromal tumor (EGIST) found diffusely in the abdominal cavity. Treatment with imatinib showed significant improvement in symptoms and tumor reduction.
Area of Science:
- Gastrointestinal Oncology
- Surgical Pathology
- Medical Genetics
Background:
- Extragastrointestinal stromal tumors (EGIST) share pathological similarities with gastrointestinal stromal tumors.
- EGISTs are rare neoplasms that can arise anywhere along the gastrointestinal tract or adjacent structures.
Observation:
- A 71-year-old male presented with abdominal pain and was diagnosed with diffuse EGIST in the abdominal cavity.
- Imaging revealed multiple nodules, enlarged lymph nodes, and pulmonary nodules, with elevated CA-125.
- Intraoperative findings included diffuse tuberous tumors and hematocelia, confirmed as EGIST post-pathology.
Findings:
- Gene testing identified variations in breast cancer susceptibility gene 1 interacting protein C-terminal helicase 1 and KIT.
- The patient received imatinib therapy, leading to symptom resolution.
- Post-treatment imaging demonstrated significant alleviation of tumor burden.
Implications:
- This case highlights the potential for diffuse EGIST in membranous tissues and its response to targeted therapy.
- Understanding genetic variations is crucial for effective treatment strategies in EGIST.
- Imatinib demonstrates therapeutic efficacy in managing complex EGIST presentations.
More Related Videos
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Esophageal Varices-I: Introduction

